Health-related quality of life in severe hypersensitivity reactions: focus on severe allergic asthma and hymenoptera venom anaphylaxis—a cross-sectional study
immunology
hymenoptera venom anaphylaxis
03 medical and health sciences
0302 clinical medicine
H-R quality of life
Psychology
severe allergic asthma
clinical psychology
alexithymia
H-R quality of life, alexithymia, clinical psychology, hymenoptera venom anaphylaxis, immunology, outdoor workers, severe allergic asthma, severe hypersensitivity reactions
BF1-990
DOI:
10.3389/fpsyg.2024.1394954
Publication Date:
2024-08-23T04:59:04Z
AUTHORS (11)
ABSTRACT
BackgroundGrowing evidence reveals the important role of clinical psychological factors in chronic-immune diseases. The aim of this study was to investigate Health-Related Quality of Life (HR-QoL), depression, anxiety, and alexithymia in patients with severe hypersensitivity reactions such as Severe Allergic Asthma (SAA) and Hymenoptera Venom Anaphylaxis (HVA).MethodsThe Short-Form Health Survey-36 (SF-36), the Beck Depression Inventory Questionnaire (BDI-II), the Hamilton Anxiety Rating Scale (HAM-A) and the Toronto Alexithymia Scale (TAS-20) were used to assess HR-QoL and clinical psychological features of patients with SAA and HVA.ResultsOverall, 78 patients were recruited. Patients with SAA (n = 35) reported lower scores for physical functioning [65 (58–75) vs. 90 (85–95); p = <0.001], role limitations due to physical health [25 (0–50) vs. 62 (50–75); p = 0.004], bodily pain [47.5 (41.1–61.3) vs. 55.5 (55–96); p = 0.001], general health [40 (30–60) vs. 70 (50–80); p = 0.0003] and social functioning [50 (37.5–62.5) vs. 62.5 (54.9–75); p = 0.007] while higher scores for depressive symptoms [14 (11–15.4) vs. (9.5 (6–15.4); p = 0.05)] compared to HVA patients (n = 43). All the dimensions of SF-36 were negatively correlated with anxiety (r from −0.26 to −0.66; pall < 0.01) and depressive symptoms (r from −0.44 to −0.73; pall < 0.001). Alexithymia was negatively correlated with vitality (r = −0.28; p = 0.02) and mental health (r = −027; p = 0.03). Additionally, patients with alexithymia (38% of participants) showed higher levels of depressive symptoms [9.5 (10–19) vs. 14 (6–13.9); p = 0.005] and anxiety levels [31 (27.9–35) vs. 24 (16–33.9); p = 0.02]; they also showed less vitality [40 (39.9–50) vs. 55 (50–60) p = 0.01], social functioning [50 (37.5–62.5) vs. 62.5 (50 vs. 75); p = 0.01] and mental health [48 (44–60) vs. 68 (56–76); p = 0.004].ConclusionClinical psychological features due to severe hypersensitive reactions may contribute to the patient’s perceived HR-QoL. Focused clinical psychological interventions should be promoted to improve the clinical management of such conditions.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (77)
CITATIONS (1)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....